A Pilot Randomized, Clinical Trial of the Anti-pruritus Effect of Melatonin in Patients with Chronic Liver Disease

AuthorAyda Esmaeili
AuthorMohssen Nassiri Toosi
AuthorMohammad Taher
AuthorShahin Merat
AuthorJaleh Bayani
AuthorZahra fruzan. Karimian
AuthorAysan Esmaeili
AuthorBobak Moazzami
AuthorSoha Namazi
Issued Date2021-04-30
AbstractPruritus is one of the disturbing complications induced by chronic liver disease (CLD), bearing a negative impact on patient quality of life and potentially resulting in early liver transplants. Given the main role of the autotaxin enzyme in pruritus induced by CLD and the suppressive effects of melatonin on the expression of the autotaxin gene, this study was designed to evaluate the antipruritic effect of melatonin in patients with CLD. A double-blind, cross-over, randomized, placebo-controlled pilot trial was conducted on patients with CLD -induced pruritis. Patients were randomly assigned to two groups where they received melatonin 10-mg at night or placebo for 2 weeks. After a 2-week washout period, patients were then crossed over to the other group. The Visual Analog Scale (VAS) and the 12-Item Pruritus Severity Score (12-PSS) were used to assess patient response to therapy as the co-primary outcomes, while liver function tests were assayed too. Forty patients completed the study. The VAS score showed alleviation of 3.21 ± 2.24 (in pruritus) with melatonin (p-value
DOIhttps://doi.org/10.22037/ijpr.2020.112942.14024
KeywordMelatonin
KeywordPruritus
KeywordChronic liver disease
KeywordVisual analog scale
Keyword12-Item pruritus severity score
PublisherBrieflands
TitleA Pilot Randomized, Clinical Trial of the Anti-pruritus Effect of Melatonin in Patients with Chronic Liver Disease
TypeOriginal Article_imported
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-20-462.pdf
Size:
452.28 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF